Correlation Between Sartorius Stedim and Scandinavian Tobacco

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Scandinavian Tobacco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Scandinavian Tobacco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Scandinavian Tobacco Group, you can compare the effects of market volatilities on Sartorius Stedim and Scandinavian Tobacco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Scandinavian Tobacco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Scandinavian Tobacco.

Diversification Opportunities for Sartorius Stedim and Scandinavian Tobacco

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sartorius and Scandinavian is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Scandinavian Tobacco Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scandinavian Tobacco and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Scandinavian Tobacco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scandinavian Tobacco has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Scandinavian Tobacco go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Scandinavian Tobacco

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 2.47 times more return on investment than Scandinavian Tobacco. However, Sartorius Stedim is 2.47 times more volatile than Scandinavian Tobacco Group. It trades about 0.26 of its potential returns per unit of risk. Scandinavian Tobacco Group is currently generating about 0.37 per unit of risk. If you would invest  18,650  in Sartorius Stedim Biotech on October 25, 2024 and sell it today you would earn a total of  2,055  from holding Sartorius Stedim Biotech or generate 11.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Scandinavian Tobacco Group

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Scandinavian Tobacco 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scandinavian Tobacco Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Scandinavian Tobacco is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Sartorius Stedim and Scandinavian Tobacco Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Scandinavian Tobacco

The main advantage of trading using opposite Sartorius Stedim and Scandinavian Tobacco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Scandinavian Tobacco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scandinavian Tobacco will offset losses from the drop in Scandinavian Tobacco's long position.
The idea behind Sartorius Stedim Biotech and Scandinavian Tobacco Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital